近十年来心肌梗塞的内科治疗,获得了新的进展。其病死率在国外已降至17%以下。最近我国1215例急性心肌梗塞的病死率为12.2%。心肌梗塞伴有心力衰竭和休克,常规或传统的正性肌力药物(交感胺类)和升压药物疗法,虽然可以暂时升高血压,但大多数学者认为,并不能降低病死率(仍然为80—90%)。当然,对严重心源性休克患者,当心肌功能十分低下,体循环血压极度下降时,使用 In recent ten years, the medical treatment of myocardial infarction has made new progress. Its case fatality rate has dropped below 17% in foreign countries. Recently 1215 cases of acute myocardial infarction mortality in China was 12.2%. Myocardial infarction associated with heart failure and shock, conventional or traditional inotropes (sympathomical amines) and vasopressor therapy, although temporarily elevated in blood pressure, are not considered by most scholars to reduce mortality (still 80-90%). Of course, patients with severe cardiogenic shock, when the myocardial function is very low, extreme decline in systemic blood pressure, the use of